Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
The hepatocyte nuclear factor-4α (HNF4α) and hepatocyte nuclear factor-1α (HNF1α) are transcription factors that influence the development and maintenance of homeostasis in a variety of tissues, including the liver. As such, disruptions in their transcriptional networks can herald a number of pathol...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a03c20a0c544ba5af6e3277f3e3c350 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4a03c20a0c544ba5af6e3277f3e3c350 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4a03c20a0c544ba5af6e3277f3e3c3502021-11-11T15:28:57ZDisruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver10.3390/cancers132153572072-6694https://doaj.org/article/4a03c20a0c544ba5af6e3277f3e3c3502021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5357https://doaj.org/toc/2072-6694The hepatocyte nuclear factor-4α (HNF4α) and hepatocyte nuclear factor-1α (HNF1α) are transcription factors that influence the development and maintenance of homeostasis in a variety of tissues, including the liver. As such, disruptions in their transcriptional networks can herald a number of pathologies, such as tumorigenesis. Largely considered tumor suppressants in liver cancer, these transcription factors regulate key events of inflammation, epithelial–mesenchymal transition, metabolic reprogramming, and the differentiation status of the cell. High-throughput analysis of cancer cell genomes has identified a number of hotspot mutations in HNF1α and HNF4α in liver cancer. Such results also showcase HNF1α and HNF4α as important therapeutic targets helping us step into the era of personalized medicine. In this review, we update current findings on the roles of HNF1α and HNF4α in liver cancer development and progression. It covers the molecular mechanisms of HNF1α and HNF4α dysregulation and also highlights the potential of HNF4α as a therapeutic target in liver cancer.Aamir Salam TeeliKamila ŁuczyńskaEffi HaqueMohmmad Abrar GayasDawid WiniarczykHiroaki TaniguchiMDPI AGarticlehepatocellular carcinomaHNF4αHNF1αinflammationβ-cateninEMTNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5357, p 5357 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
hepatocellular carcinoma HNF4α HNF1α inflammation β-catenin EMT Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
hepatocellular carcinoma HNF4α HNF1α inflammation β-catenin EMT Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Aamir Salam Teeli Kamila Łuczyńska Effi Haque Mohmmad Abrar Gayas Dawid Winiarczyk Hiroaki Taniguchi Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver |
description |
The hepatocyte nuclear factor-4α (HNF4α) and hepatocyte nuclear factor-1α (HNF1α) are transcription factors that influence the development and maintenance of homeostasis in a variety of tissues, including the liver. As such, disruptions in their transcriptional networks can herald a number of pathologies, such as tumorigenesis. Largely considered tumor suppressants in liver cancer, these transcription factors regulate key events of inflammation, epithelial–mesenchymal transition, metabolic reprogramming, and the differentiation status of the cell. High-throughput analysis of cancer cell genomes has identified a number of hotspot mutations in HNF1α and HNF4α in liver cancer. Such results also showcase HNF1α and HNF4α as important therapeutic targets helping us step into the era of personalized medicine. In this review, we update current findings on the roles of HNF1α and HNF4α in liver cancer development and progression. It covers the molecular mechanisms of HNF1α and HNF4α dysregulation and also highlights the potential of HNF4α as a therapeutic target in liver cancer. |
format |
article |
author |
Aamir Salam Teeli Kamila Łuczyńska Effi Haque Mohmmad Abrar Gayas Dawid Winiarczyk Hiroaki Taniguchi |
author_facet |
Aamir Salam Teeli Kamila Łuczyńska Effi Haque Mohmmad Abrar Gayas Dawid Winiarczyk Hiroaki Taniguchi |
author_sort |
Aamir Salam Teeli |
title |
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver |
title_short |
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver |
title_full |
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver |
title_fullStr |
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver |
title_full_unstemmed |
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver |
title_sort |
disruption of tumor suppressors hnf4α/hnf1α causes tumorigenesis in liver |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/4a03c20a0c544ba5af6e3277f3e3c350 |
work_keys_str_mv |
AT aamirsalamteeli disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver AT kamilałuczynska disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver AT effihaque disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver AT mohmmadabrargayas disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver AT dawidwiniarczyk disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver AT hiroakitaniguchi disruptionoftumorsuppressorshnf4ahnf1acausestumorigenesisinliver |
_version_ |
1718435237277466624 |